Abstract:Endothelial cells adopt tissue-specific characteristics to instruct organ development and regeneration1,2. This adaptability is lost in cultured adult endothelial cells, which do not vascularize tissues in an organotypic manner. Here, we show that transient reactivation of the embryonic-restricted ETS variant transcription factor 2 (ETV2)3 in mature human endothelial cells cultured in a serum-free three-dimensional matrix composed of a mixture of laminin, entactin and type-IV collagen (LEC matrix) 'resets' these endothelial cells to adaptable, vasculogenic cells, which form perfusable and plastic vascular plexi. Through chromatin remodelling, ETV2 induces tubulogenic pathways, including the activation of RAP1, which promotes the formation of durable lumens4,5. In three-dimensional matrices-which do not have the constraints of bioprinted scaffolds-the 'reset' vascular endothelial cells (R-VECs) self-assemble into stable, multilayered and branching vascular networks within scalable microfluidic chambers, which are capable of transporting human blood. In vivo, R-VECs implanted subcutaneously in mice self-organize into durable pericyte-coated vessels that functionally anastomose to the host circulation and exhibit long-lasting patterning, with no evidence of malformations or angiomas. R-VECs directly interact with cells within three-dimensional co-cultured organoids, removing the need for the restrictive synthetic semipermeable membranes that are required for organ-on-chip systems, therefore providing a physiological platform for vascularization, which we call 'Organ-On-VascularNet'. R-VECs enable perfusion of glucose-responsive insulin-secreting human pancreatic islets, vascularize decellularized rat intestines and arborize healthy or cancerous human colon organoids. Using single-cell RNA sequencing and epigenetic profiling, we demonstrate that R-VECs establish an adaptive vascular niche that differentially adjusts and conforms to organoids and tumoroids in a tissue-specific manner. Our Organ-On-VascularNet model will permit metabolic, immunological and physiochemical studies and screens to decipher the crosstalk between organotypic endothelial cells and parenchymal cells for identification of determinants of endothelial cell heterogeneity, and could lead to advances in therapeutic organ repair and tumour targeting.

A Pulmonary Vascular Model From Endothelialized Whole Organ Scaffolds

Abstract 14125: An in vitro Pulmonary Vascular Platform From Endothelialized Whole Lung Scaffolds

Engineered Whole Lungs for Tissue Biology

Enhanced Re-Endothelialization of Decellularized Rat Lungs

Advancements in Preclinical Human-Relevant Modeling of Pulmonary Vasculature On-Chip

Angiorganoid: Vitalizing the Organoid with Blood Vessels.

Ex Vivotissue Perturbations Coupled to Single Cell RNA-seq Reveal Multi-Lineage Cell Circuit Dynamics in Human Lung Fibrogenesis

Constructing biomimetic liver models through biomaterials and vasculature engineering

Non-invasive and real-time measurement of microvascular barrier in intact lungs

3D bioprinted vascularized lung cancer organoid models with underlying disease capable of more precise drug evaluation

Adaptable haemodynamic endothelial cells for organogenesis and tumorigenesis

Physiological Modeling of the Vascularized Human Lung Organoid.

3D Human iPSC Blood Vessel Organoids as a Source of Flow‐Adaptive Vascular Cells for Creating a Human‐Relevant 3D‐Scaffold Based Macrovessel Model

Primary Human Lung Pericytes Support and Stabilize In Vitro Perfusable Microvessels.

Epac agonist improves barrier function in iPSC-derived endothelial colony forming cells for whole organ tissue engineering

Engineering vascularised organoid-on-a-chip: strategies, advances and future perspectives

Deciphering Endothelial and Mesenchymal Organ Specification in Vascularized Lung and Intestinal Organoids

Soluble ECM promotes organotypic formation in lung alveolar model

Histological study of an experimentally constructed decellularized rat lung as a model of whole organ three-dimensional natural scaffold

Endothelialized Bronchioalveolar Lung Organoids Model Endothelial Cell Responses to Injury

Transplantation of bioengineered lung using decellularized mouse lungs and primary human endothelial cells.